SELLAS Life Sciences' value hinges on the pivotal REGAL phase 3 trial in AML, with interim results showing promise, but final outcomes still unknown. Despite encouraging data, I remain highly cautious ...
NEW YORK--(BUSINESS WIRE)--Builds Bio+, the premier life science membership organization that connects all segments of the life sciences ecosystem across major regional clusters, today announced the ...
Atai Life Sciences announced positive results from Beckley Psytech's Phase 2a study of BPL-003, an adjunctive treatment for patients with treatment-resistant depression (TRD) who are already on ...
Caris Life Sciences® today announced the presentation of a study that found drugs targeting specific pathways may have potentially significant benefit in a select subset of patients with uterine ...
A new study suggests that psilocybin, also known as magic mushrooms, could extend lifespan. Researchers at the Emory University Department of Medicine in Atlanta, Georgia, discovered that psilocybin ...
This activity was supported by the National Academy of Sciences and the U.S. Department of Defense and the Army Research Office (Contract No. W911NF-23-D-0002). Any opinions, findings, conclusions, or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results